Search
Tuesday 9 June 2015
  • :
  • :
Latest Update

Active Stocks Alert: AFLAC Incorporated (NYSE:AFL), Terex Corporation (NYSE:TEX), Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), Automatic Data Processing (NASDAQ:ADP)

On Thursday, in the course of current trade, Shares of AFLAC Incorporated (NYSE:AFL), climbed 0.11%, and is now trading at $62.61.

AFLAC Incorporated released by Aflac, the leading provider of voluntary insurance at the work site in the United States, reveal wide disparities between higher- and lower-income households in terms of financial preparedness, knowledge about health insurance and benefits enrollment. For example, 55 percent of employees in lower-income households are not prepared to pay for costs associated with an unanticipated serious illness or accident not covered by major medical insurance, contrast with only 20 percent of employees in higher-income households. This lack of readiness may present economic and health risks for households already walking a financial tightrope without a safety net to cope with raised medical costs.

The online study, conducted by Research Now on behalf of Aflac between January and February 2015, surveyed 1,977 employers and 5,337 employees at small, medium and large U.S. companies, shedding light on how employees at different ends of the household income spectrum are responding to the continued high cost of health care and the shift to greater consumer control over, and responsibility for, medical expenses.

Aflac Incorporated, through its partner, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance products.

During Morning trade, Shares of Terex Corporation (NYSE:TEX), dipped -0.60%, and is now trading at $ 24.97.

Terex Corporation, declared that it has closed a new $350 million asset-backed securitization transaction.

The Company also declared it has accomplished a re-pricing of its Euro term loan that is predictable to reduce its cash interest costs by about $1 million annually.

The commercial paper conduit facility will finance and is secured by equipment loan and lease receivables originated by TFS in the United States and Canada. The new facility will supplement TFS’s ability to provide customer solutions for Terex equipment financing, adding to the existing underwriting, warehousing and syndication practices already in place.

Terex Corporation operates as a lifting and material handling solutions company. Its Aerial Work Platforms segment designs, manufactures, services, and markets aerial work platform equipment, telehandlers, and light towers, in addition to related components and replacement parts under Terex and Genie names.

Shares of Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), during its Thursday’s current trading session climbed 1.89%, and is now trading at $ 3.05.

Actinium Pharmaceuticals, declared that the presentation of poster and abstract at ASCO 2015, the 51stAnnual Meeting of American Society of Clinical Oncology, was given in Chicago on May 31. Data from the Company’s ongoing multi-center Phase 1/2 Study for Actimab-A for the treatment of newly diagnosed Acute Myeloid Leukemia in elderly patients were presented by Dr. Joseph Jurcic of Columbia University Medical Center, Actinium’s Clinical Advisory Board Chairman.

Among the first 12 patients treated at increasing dose levels, two Actimab-A treated patients achieved complete remission with different degrees of hematological recovery (CRi) and one patient achieved complete remission with incomplete platelet count recovery (CRp), for a combined overall response rate of 25% among all patients and 67% among patients treated at the highest dose level to date. Patients ranged from 68 to 87 years of age, all with high- or intermediate-risk cytogenetics; half of them had preceding MDS therapy. Dose limiting toxicities were limited to one patient with prolonged myelosuppression. No extramedullary dose limiting toxicities were observed. Patients had high pre-treatment leukemia burdens of up to 88% in the bone marrow, and half had blast reductions >50% after Actimab-A treatment. The Company also began the fourth and last cohort in the Phase I portion of this trial.

Actinium Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs for the treatment of cancer. The company develops therapies for life threatening diseases using its alpha particle immunotherapy platform and other related and similar technologies.

Finally, Automatic Data Processing (NASDAQ:ADP), lost -0.24% Thursday, hitting its highest level.

Automatic Data Processing, declared that Everest Group has named it a Leader in its Multi-Country Payroll Outsourcing - Service Provider Landscape with PEAK Matrix Assessment 2015.

The research report, published in March, noted the geographic scope and scalability of ADP’s payroll solutions, citing its ability to meet the needs of very large multinational organizations, in addition to midsized business. ADP also was recognized for its global payroll domain expertise.

In particular, Everest Group singled out ADP Streamline, a global payroll solution accessible in 100 countries, and the ADP Mobile app, which has been downloaded more than four million times.

Automatic Data Processing, Inc., together with its auxiliaries, provides technology-based outsourcing solutions to employers worldwide. The company operates through Employer Services and Professional Employer Organization Services segments.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *